false
Catalog
AJSP2201 - CME/CMLE - Double PIK3CA Mutations and ...
Double PIK3CA Mutations and Parallel Evolution in ...
Double PIK3CA Mutations and Parallel Evolution in Colorectal Cancers
Back to course
Pdf Summary
The study focuses on the clinicopathologic features and clonality of double PIK3CA alterations in colorectal cancers (CRCs). These alterations, which increase oncogenicity and sensitivity to PI3Kα inhibitors, were detected in a subset of CRCs. Most double PIK3CA alterations were found to be clonal and within a single tumor population. Multiregional analyses revealed multiclonal CRCs with divergent PIK3CA variant status originating from a common lineage of adenoma. The study suggests that multiclonality in CRCs results from parallel evolution within the mTOR pathway, similar to the evolution within the MAPK pathway.<br /><br />This research expands on the understanding of double PIK3CA alterations in CRCs and highlights the potential for targeted therapy and impacts on clinical decision-making for patients with multiclonal CRCs. The study also discusses the challenges of analyzing mutations within the same signaling pathway, as well as the importance of accurate clonality predictions in understanding tumor evolution and guiding treatment strategies. Further studies are needed to explore the clinical significance of double PIK3CA alterations and to evaluate the efficacy of PI3Kα inhibitors in CRC patients with these mutations. The study underscores the complexity of tumor evolution and the importance of molecular profiling in informing precision medicine approaches for colorectal cancer patients.
Keywords
clinicopathologic features
double PIK3CA alterations
colorectal cancers
oncogenicity
PI3Kα inhibitors
clonality
multiclonal CRCs
mTOR pathway
MAPK pathway
precision medicine
×
Please select your language
1
English